Hansa Biopharma AB (publ) (HNSA.ST)

SEK 33.3

(17.42%)

Annual Balance Sheets

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.01 Billion 1.68 Billion 1.01 Billion 1.43 Billion 664.23 Million 944.82 Million
Total Current Assets 855.15 Million 1.6 Billion 942.34 Million 1.39 Billion 615.74 Million 866.22 Million
Cash And Short Term Investments 732.06 Million 1.49 Billion 888.96 Million 1.37 Billion 601.09 Million 858.18 Million
Cash and Cash Equivalents 732.06 Million 1.49 Billion 651.34 Million 1.13 Billion 181.69 Million 439.44 Million
Short Term Investments - - 237.61 Million 238.14 Million 419.39 Million 418.74 Million
Net Receivables 91.75 Million 107.55 Million 20.95 Million 6.94 Million 5.25 Million 7.1 Million
Inventory 9.79 Million 973 Thousand 242 Thousand 98 Thousand -1000.00 -7.1 Million
Other Current Assets 21.54 Million 1000.00 20.88 Million 5.71 Million 9.39 Million 8.03 Million
Total Non-Current Assets 162.89 Million 82.7 Million 70.46 Million 41.1 Million 48.49 Million 78.6 Million
Net PPE 27.07 Million 35.83 Million 45.78 Million 9.7 Million 15.14 Million 5.87 Million
Good Will And Intangible Assets 135.81 Million 46.86 Million 28.76 Million 31.41 Million 33.34 Million 33.19 Million
Good Will - - - - - -
Intangible Assets 135.81 Million 46.86 Million 28.76 Million 31.41 Million 33.34 Million 33.19 Million
Long-Term Investments - - - - - -379.21 Million
Tax Assets - - - - - -
Other Non Current Assets - - -4.07 Million -1000.00 1000.00 418.74 Million
Other Assets - - - - - -
Total Liabilities 1.18 Billion 1.08 Billion 255.23 Million 192.37 Million 101.42 Million 84.94 Million
Total Current Liabilities 320.98 Million 264.71 Million 171.21 Million 114.2 Million 94.54 Million 72.33 Million
Account Payables 86.96 Million 62.47 Million 53.36 Million 26.66 Million 50.57 Million 40.42 Million
Tax Payables 1.59 Million 762 Thousand 190 Thousand 134 Thousand 319 Thousand -
Short Term Debt 7.5 Million 7.16 Million 6.88 Million 4.41 Million 4.63 Million 101 Thousand
Deferred Revenue 41.47 Million 40.43 Million 24.96 Million 83.12 Million - 31.69 Million
Other Current Liabilities 185.04 Million 154.64 Million 86.01 Million -2000.00 39.33 Million 106 Thousand
Total Non Current Liabilities 864.92 Million 819.78 Million 84.01 Million 78.16 Million 6.88 Million 12.61 Million
Long-Term Debt 844.9 Million 783.92 Million 28.49 Million 630 Thousand 4.82 Million 476 Thousand
Deferred Revenue Non Current 14.36 Million 29.5 Million 47.02 Million 62.02 Million 818 Thousand 10.94 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 5.29 Million 5.94 Million 8.07 Million 15.08 Million 729 Thousand 679 Thousand
Other Liabilities 1.00 - - - - -
Total Equity -167.87 Million 602.91 Million 757.57 Million 1.24 Billion 562.81 Million 859.87 Million
Stock Holders Equity -167.87 Million 602.91 Million 757.57 Million 1.24 Billion 562.81 Million 859.87 Million
Common Stock 55.03 Million 55.03 Million 46.33 Million 45.89 Million 41.44 Million 40.68 Million
Retained Earnings -3.3 Billion -2.47 Billion -1.85 Billion -1.31 Billion -971.82 Million -611.49 Million
Accumulated other comprehensive income -408 Thousand 13 Thousand 127 Thousand -137 Thousand 81.16 Million 31.21 Million
Common Stock Equity -167.87 Million 602.91 Million 757.57 Million 1.24 Billion 562.81 Million 859.87 Million
Capital Lease Obligation 14.36 Million 28.49 Million 35.37 Million 5.04 Million 9.45 Million 577 Thousand
Total Investments - - 237.61 Million 238.14 Million 419.39 Million 39.52 Million
Total Debt 866.76 Million 791.09 Million 35.37 Million 5.04 Million 9.45 Million 577 Thousand
Net Debt 134.7 Million -705.08 Million -615.96 Million -1.13 Billion -172.23 Million -438.86 Million

Balance Sheet Charts